Detalhe da pesquisa
1.
Overcoming T-cell exhaustion in LCH: PD-1 blockade and targeted MAPK inhibition are synergistic in a mouse model of LCH.
Blood
; 137(13): 1777-1791, 2021 04 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-33075814
2.
CNS Langerhans cell histiocytosis: Common hematopoietic origin for LCH-associated neurodegeneration and mass lesions.
Cancer
; 124(12): 2607-2620, 2018 06 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-29624648
3.
BRAF V600E vs cell of origin: what governs LCH?
Blood
; 138(14): 1203-1204, 2021 10 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34618000
4.
Alternative genetic mechanisms of BRAF activation in Langerhans cell histiocytosis.
Blood
; 128(21): 2533-2537, 2016 11 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-27729324
5.
New somatic BRAF splicing mutation in Langerhans cell histiocytosis.
Mol Cancer
; 16(1): 115, 2017 07 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-28679432
6.
Redox regulation of interleukin-4 signaling.
Immunity
; 29(4): 551-64, 2008 Oct 17.
Artigo
em Inglês
| MEDLINE | ID: mdl-18957266
7.
Evaluation of maternal and perinatal characteristics on childhood lymphoma risk: A population-based case-control study.
Pediatr Blood Cancer
; 64(5)2017 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-27896915
8.
Mutually exclusive recurrent somatic mutations in MAP2K1 and BRAF support a central role for ERK activation in LCH pathogenesis.
Blood
; 124(19): 3007-15, 2014 Nov 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-25202140
9.
Langerhans Cell Histiocytosis: Emerging Insights and Clinical Implications.
Oncology (Williston Park)
; 30(2): 122-32, 139, 2016 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-26888790
10.
Differentiating skin-limited and multisystem Langerhans cell histiocytosis.
J Pediatr
; 165(5): 990-6, 2014 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-25441388
11.
A genome-wide association study of LCH identifies a variant in SMAD6 associated with susceptibility.
Blood
; 130(20): 2229-2232, 2017 11 16.
Artigo
em Inglês
| MEDLINE | ID: mdl-28935696
12.
Autologous HER2-specific CAR T cells after lymphodepletion for advanced sarcoma: a phase 1 trial.
Nat Cancer
; 2024 Apr 24.
Artigo
em Inglês
| MEDLINE | ID: mdl-38658775
13.
Robust and cost effective expansion of human regulatory T cells highly functional in a xenograft model of graft-versus-host disease.
Haematologica
; 98(4): 533-7, 2013 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-23242592
14.
Activation of Wnt signaling arrests effector differentiation in human peripheral and cord blood-derived T lymphocytes.
J Immunol
; 187(10): 5221-32, 2011 Nov 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-22013128
15.
MAP-Kinase-Driven Hematopoietic Neoplasms: A Decade of Progress in the Molecular Age.
Cold Spring Harb Perspect Med
; 11(5)2021 05 03.
Artigo
em Inglês
| MEDLINE | ID: mdl-32601132
16.
BRAFV600E-induced senescence drives Langerhans cell histiocytosis pathophysiology.
Nat Med
; 27(5): 851-861, 2021 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-33958797
17.
IFN-γ signature in the plasma proteome distinguishes pediatric hemophagocytic lymphohistiocytosis from sepsis and SIRS.
Blood Adv
; 5(17): 3457-3467, 2021 09 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-34461635
18.
Circulating CD1c+ myeloid dendritic cells are potential precursors to LCH lesion CD1a+CD207+ cells.
Blood Adv
; 4(1): 87-99, 2020 01 14.
Artigo
em Inglês
| MEDLINE | ID: mdl-31899802
19.
Defining the Inflammatory Plasma Proteome in Pediatric Hodgkin Lymphoma.
Cancers (Basel)
; 12(12)2020 Dec 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-33276546
20.
RAF/MEK/extracellular signal-related kinase pathway suppresses dendritic cell migration and traps dendritic cells in Langerhans cell histiocytosis lesions.
J Exp Med
; 215(1): 319-336, 2018 01 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-29263218